Device Trial Radar · NCT01922024
Detection of Microorganisms and Antibiotic Resistance Genes Using the Curetis Unyvero LRT55 Application
Last checked: Nov 20, 2026Latest source record: Mar 5, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
2,124
Actual
Start
Jun 2015
Primary completion
Nov 2016
Study completion Nov 2016
Sponsor
- Lead sponsor
- Curetis GmbHNot on our public-company list
- Sponsor type
- Industry
- Collaborators
- Global BioClinical
- First posted
- Aug 14, 2013
Design
- Study type
- Observational
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The Curetis Unyvero LRT55 Application is intended to detect and to identify genes of 21 microorganisms and 19 genes associated with antibiotic resistance in 4 hours. In this study, the performance of the Unyvero LRT55 Application shall be tested under clinical conditions and compared to (1) a composite reference method (for non-atypical or cultured microorganisms) or (2) a molecular PCR based reference method for the 3 atypical microorganisms Chlamydophila pneumoniae, Legionella pneumoniae, and Pneumocystis jirovecii, and for resistance genes. PCR amplifications are followed by bi-directional sequencing, including comparison of the test results Time to result will be compared for the Unyvero LRT55 Application and standard-of care.
Conditions
- Pneumonia
Interventions
LRT55 TestingDevice
Testing on the Unyvero LRT55
Primary outcomes
What the sponsor says the trial is designed to measure.
- Clinical Sensitivity and Specificity for Microorganism Detection as Compared to Routine Microbiology and Other Reference Methods Including PCR and SequencingTime frame: Up to 12 months
Locations
9 sites in 1 country. Site status is shown where the registry gives one.
University of California Los Angeles (UCLA)
Los Angeles, California
8 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.